These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32956105)

  • 1. Tardive syndrome: An update and mini-review from the perspective of phenomenology.
    Chen CY; Chiang HL; Fuh JL
    J Chin Med Assoc; 2020 Dec; 83(12):1059-1065. PubMed ID: 32956105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nosology of tardive syndromes.
    Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
    J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.
    Hauser RA; Meyer JM; Factor SA; Comella CL; Tanner CM; Xavier RM; Caroff SN; Lundt L
    CNS Spectr; 2022 Apr; 27(2):208-217. PubMed ID: 33213556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic-induced tardive dyskinesia: update on epidemiology and management.
    Widschwendter CG; Hofer A
    Curr Opin Psychiatry; 2019 May; 32(3):179-184. PubMed ID: 30720484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on tardive dyskinesia: from phenomenology to treatment.
    Waln O; Jankovic J
    Tremor Other Hyperkinet Mov (N Y); 2013; 3():. PubMed ID: 23858394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive syndromes.
    Savitt D; Jankovic J
    J Neurol Sci; 2018 Jun; 389():35-42. PubMed ID: 29506749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Setting the record straight: The nosology of tardive syndromes.
    Truong DD; Frei K
    Parkinsonism Relat Disord; 2019 Feb; 59():146-150. PubMed ID: 30528171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.
    Dilks S; Xavier RM; Kelly C; Johnson J
    Nurs Clin North Am; 2019 Dec; 54(4):595-608. PubMed ID: 31703784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Tardive Syndrome: Medications and Surgical Treatments.
    Factor SA
    Neurotherapeutics; 2020 Oct; 17(4):1694-1712. PubMed ID: 32720245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Spectrum of Drug-Induced Movement Disorders: A Study of 97 Patients.
    Chouksey A; Pandey S
    Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():48. PubMed ID: 33178486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Treatments for Tardive Dyskinesia].
    Nomoto M
    Brain Nerve; 2022 May; 74(5):565-570. PubMed ID: 35589648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antipsychotic-induced tardive syndromes].
    Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
    Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
    Bhidayasiri R; Jitkritsadakul O; Friedman JH; Fahn S
    J Neurol Sci; 2018 Jun; 389():67-75. PubMed ID: 29454493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and treatment of tardive syndromes.
    Fernandez HH; Friedman JH
    Neurologist; 2003 Jan; 9(1):16-27. PubMed ID: 12801428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment.
    Correll CU; Kane JM; Citrome LL
    J Clin Psychiatry; 2017; 78(8):1136-1147. PubMed ID: 29022654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical perspectives on tardive dyskinesia.
    Caroff SN; Ungvari GS; Cunningham Owens DG
    J Neurol Sci; 2018 Jun; 389():4-9. PubMed ID: 29454494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced tardive syndromes.
    Ortí-Pareja M; Jiménez-Jiménez FJ; Vázquez A; Catalán MJ; Zurdo M; Burguera JA; Martínez-Martín P; Molina JA;
    Parkinsonism Relat Disord; 1999 Apr; 5(1-2):59-65. PubMed ID: 18591121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
    Patra S
    Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.